FOXO TECHNOLOGIES INC.

FOXO Technologies Inc. (NYSE American: FOXO) is a Minneapolis-based insurtech company that became publicly traded through a business combination with CF Acquisition Corp VIII, a SPAC sponsored by Cantor Fitzgerald, which completed its IPO in 2021. The company operates in the life insurance technology sector, focusing on the application of epigenetic biomarker science to modernize underwriting and policyholder engagement. The July 2026 Form 8-K filing, submitted under accession number 0001493152-26-031543, represents the company's continued post-merger public reporting obligations. Investors and analysts tracking FOXO's corporate developments and SPAC transaction history can access full filing data, deal timelines, and sponsor profiles by signing up for SpacDesk.